Detalhe da pesquisa
1.
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Lancet Oncol
; 19(3): 370-381, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29429912
2.
Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.
Haematologica
; 103(3): 438-446, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217781
3.
Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups.
Br J Haematol
; 162(6): 783-91, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23848933